Bayesian Capital Management, LP Clearside Biomedical, Inc. Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
34Shares Held
7.39MCall Options Held
0Put Options Held
0-
Act Capital Management, LLC Wayne, PA2.2MShares$8.17 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$5.61 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$2.97 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$2.94 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny497KShares$1.85 Million0.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $224M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...